Mechanisms for human cytomegalovirus-induced cytoplasmic p53 sequestration in endothelial cells

Journal of Cell Science

Volumn 119, Issue 12, 2006, Pages 2457-2467

  Utama, Budi ^a   Shen, Ying H ^a   Mitchell, Bradley M ^a   Makagiansar, Irwan T ^b   Gan, Yehua ^a   Muthuswamy, Raveendran ^a   Duraisamy, Senthil ^a   Martin, David ^c   Wang, Xinwen ^a   Zhang, Ming Xiang ^a   Wang, Jing ^a   Wang, Jian ^a   Vercellotti, Greg M ^d   Gu, Wei ^e   Wang, Xing Li ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c VRL Laboratories   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Endothelial dysfunction; Human cytomegalovirus; p53

Indexed keywords

CYCLOHEXIMIDE; LEPTOMYCIN B; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL TRANSPORT; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOPLASM; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; UBIQUITINATION; VIRUS PATHOGENESIS;

APOPTOSIS; CELL NUCLEUS; CELLS, CULTURED; CYCLOHEXIMIDE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOPLASM; ENDOTHELIAL CELLS; HUMANS; KARYOPHERINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

HUMAN HERPESVIRUS 5;

EID: 33746040882     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02974     Document Type: Article

References (52)

1. Blanchette, P., Cheng, C. Y., Yan, Q., Ketner, G., Ornelles, D. A., Dolner, T., Conaway, R. C., Conaway, J. W. and Branton, P. E. (2004). Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53. Mol. Cell. Biol. 24, 9619-9629.
2. Boutell, C. and Everett, R. D. (2003). The herpes simplex virus type 1 (HSV-1) regulatory protein ICPO interacts with and Ubiquitinates p53. J. Biol. Chem. 278, 36596-36602.
3. Castillo, J. P., Frame, E M., Rogoff, H. A., Pickering, M. T., Yurochko, A. D. and Kowalik, T. F (2005). Human cytomegalovirus IEI-72 activates ataxia telangiectasia mutated kinase and a p53/p2l -mediated growth arrest response. J Virol. 79, 11467-11475.
4. Chao, C., Saito, S., Kang, J., Anderson, C. W., Appella, E. and Xu, Y. (2000). p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 19, 4967-4975.
5. Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M. and Green, D. R. (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014.
6. Chou, S. W. and Scott, K. M. (1998). Rapid quantitation of cytomegalovirus and assay of neutralizing antibody by using monoclonal antibody to the major immediate-early viral protein. J. Clin. Microbiol. 26, 504-507.
7. Cummins, J. M. and Vogelstein, B. (2004). HAUSP is required for p53 destabilization. Cell Cycle 3, 689-692.
8. Erster, S., Mihara, M., Kim, R. H., Petrenko, O. and Moll, U. M. (2004). In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol. Cell. Biol. 24,6729-6741.
9. Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H. and Weissman, A. M. (2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945-8951.
10. Fornerod, M., Ohno, M., Yoshida, M. and Mattaj, I. W. (1997). CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051-1060.
11. Fortunato, E. A. and Spector, D. H. (1998). p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol. 72, 2033-2039.
12. Freedman, D. A. and Levine, A. J. (1998). Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18, 7288-7293.
13. Gan, Y., Shen, Y. H., Wang, J., Wang, X., Utama, B. and Wang, X. L. (2005). Role of histone deacetylation in cell-specific expression of endothelial nitric oxide synthase. J Biol. Chem. 280, 16467-16475.
14. Giannakakou, P., Sackett D. L., Ward, Y., Webster, K. R., Blagosklonny, M. V. and Fojo, T. (2000). p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat. Cell Biol. 2, 709-717.
15. Gu, J., Nie, L., Wiederschain, D. and Yuan, Z. M. (2001). Identification of p53 sequence elements that are required for MDM2-mediated nuclear export. Mot. Cell. Biol. 21, 8533-8546.
16. Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
17. Jaffe, E. A., Nachman, R. L., Becker, C. G. and Minick, C. R. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756.
18. Joseph, T. W., Zaika, A. and Moll, U. M. (2003). Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage. FASEB J. 17, 1622-1630.
19. Kahl, M., Siegel-Axel, D., Stenglein, S., Jahn, G. and Sinzger, C. (2000). Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J. Virol. 74, 7628-7635.
20. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B. and Fornace, A. J., Jr (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597.
21. Kovacs, A., Weber, M. L., Burns, L. J., Jacob, H. S. and Vercellotti, G. M. (1996). Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am. J. Pathol. 149, 1531-1539.
22. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V. and Kastan, M. B. (1992). Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7491-7495.
23. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J. and Gu, W. (2002). Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653.
24. Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R. and Gu, W. (2003). Monoversus polyubiquitination: differential control of p53 fateby Mdm2. Science 302, 1972-1975.
25. Lohrum, M. A., Woods, D. B., Ludwig, R. L., Balint, E. and Vousden, K. H. (2001). C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 21, 8521-8532.
26. McLure, K. G. and Lee, P. W. (1998). How p53 binds DNA as a tetramer. EMBO J 17, 3342-3350.
27. Michaelis, M., Kotchetkov, R., Vogel, J. U., Doerr, H. W. and Cinatl, J., Jr (2004). Cytomegalovirus infection blocks apoptosis in cancer cells. Cell Mot. Life Sci. 61, 1307-1316.
28. Middeler, G., Zerf, K., Jenovai, S., Thulig, A., Tschodrich-Rotter, M., Kubitscheck, U. and Peters, R. (1997). The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene 14, 1407-1417.
29. Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P. and Moll, U. M. (2003). p53 has a direct apoptogenic role at the mitochondria. Mot. Cell 11, 577-590.
30. Murphy, M., Alm, J., Walker, K. K., Hoffman, W. H., Evans, R. M., Levine, A. J. and George, D. L. (1999). Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 13, 2490-2501.
31. Ostermeyer, A. G., Runko, E., Winkfield, B., Ahn, B. and Moll, U. M. (1996). Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide. Proc. Natl. Acad. Sci. USA 93, 15190-15194.
32. Reboredo, M., Greaves, R. F. and Hahn, G. (2004). Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J. Gen. Viral. 85, 3555-3567.
33. Ryan, K. M., Phillips, A. C. and Vousden, K. H. (2001). Regulation and function of the p53 tumor suppressor protein. Curr Opin. Cell Biol. 13, 332-337.
34. Shamu, C. E., Story, C. M., Rapoport, T. A. and Ploegh, H. L. (1999). The pathway of US11 -dependent degradation of MHC class I heavy chains involves aubiquitin-conjugated intermediate. J. Cell Biol. 147, 45-58.
35. Shamu, C. E., Flierman, D., Ploegh, H. L., Rapoport, T. A. and Chan, V, (2001). Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol. Mot. Biol. Cell 12, 2546-2555.
36. Shen, Y. H., Utama, B., Wang, J., Raveendran, M., Senthil, D., Waldman, W. J., Belcher, J. D., Vereellotti, G., Martin, D., Mitchelle, B. M. et al. (2004). Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways. Circ. Res. 94, 1310-1317.
37. Shibata, T., Imaizumi, T., Tamo, W., Matsumiya, T., Kumagai, M., Cui, X. F., Yoshida, H., Takaya, S., Fukuda, I. and Satoh, K. (2002). Proteasome inhibitor MG-132 enhances the expression ofinterleukin-6 in human umbilical vein endothelial cells: Involvement of MAP/ERK kinase. Immunol. Cell Biol. 80, 226-230.
38. Shieh, S. Y., Ikeda, M., Taya, Y. and Prives, C. (1997). DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334.
39. Sinzger, C., Grefte, A., Plachter, B., Gouw, A. S., The, T. H. and Jahn, G. (1995). Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytornegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76, 741-750.
40. Speir, E., Modali, R., Huang, E. S., Leon, M. B., Shawl, F., Finkel, T. and Epstein, S. E. (1994). Potential role of human cytornegalovirus and p53 interaction in coronary restenosis. Science 265, 391-394.
41. Stewart, D., Ghosh, A. and Matlashewski, G. (2005). Involvement of nuclear export in human papillormavirus type 18 E6-mediated ubiquitination and degradation of p53. J. Virol. 79, 8773-8783.
42. Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J. and Wahl, G. M. (1999). A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcelfular localization and p53 activity by NES masking. EMBO J. 18, 1660-1672.
43. Takemoto, M., Mori, Y., Ueda, K., Kondo, K. and Yamanishi, K. (2004). Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J. Gen. Virol. 85, 869-879.
44. Turnell, A. S., Grand, R. J., Gorbea, C., Zhang, X., Wang, W., Mymryk, J. S. and Gallimore, P. H. (2000). Regulation of the 26S proteasome by adenovirus E1A. EMBO J. 19, 4759-4773.
45. Vogelstein, B., Lane, D. and Levine, A. J. (2000). Surfing the p53 network. Nature 408, 307-310.
46. Waldman, W. J., Sneddon, J. M., Stephens, R. E. and Roberts, W. H. (1989). Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J. Med. Virol. 28, 223-230.
47. Wang, J., Marker, P. H., Belcher, J. D., Wilcken, D. E., Burns, L. J., Vercellotti, G. M. and Wang, X. L. (2000). Human cytomegalovirus immediate early proteins upregulate endothelial p53 function. FEBS Lett. 474, 213-216.
48. Wang, J., Belcher, J. D., Marker, P. H., Wilcken, D. E., Vercellotti, G. M. and Wang, X. L. (2001). Cytomegalovirus inhibits p53 nuclear localization signal function. J Mol. Med. 78, 642-647.
49. Wiertz, E. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J. and Ploegh, H. L. (1996). The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769-779.
50. Zhang, X., Turnell, A. S., Gorbea, C., Mymryk, J. S., Gallimore, P. H. and Grand, R. J. (2004). The targeting of the proteasomal regulatory subunit S2 by adenovirus ElA causes inhibition of proteasomal activity and increased p53 expression. J. Biol. Chem. 279, 25122-25133.
51. Zhao, L. Y. and Liao, D. (2003). Sequestration of p53 in the cytoplasm by adenovirus type 12 E1B 55-kilodalton oncoprotein is required for inhibition of p53-mediated apoptosis. J Virol. 77, 13171-13181.
52. Zhu, H., Shen, Y. and Shenk, T. (1995). Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69, 7960-7970.